Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

TAXIS PHARMACEUTICALS INC

Group Recipients By:

Issue Date FY Summary


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Award Number	Award Title	Award Code	Budget Year	OPDIV	Action Date	Action Amount

Issue Date FY: 2026 ( Subtotal = $1,000,000 )
2026	2026	TAXIS PHARMACEUTICALS INC	9 DEERPARK DR STE J15	MONMOUTH JUNCTION	NJ	08852-1979	MIDDLESEX	USA	R44AI191886	Lead optimization of oral DHFR inhibitor for the treatment of multidrug-resistant N. gonorrhoeae infections.	000	2	NIH	5/26/2026	$1,000,000
															Subtotal = $1,000,000

Issue Date FY: 2025 ( Subtotal = $1,889,610 )
2025	2025	TAXIS PHARMACEUTICALS INC	9 DEERPARK DR STE J15	MONMOUTH JUNCTION	NJ	08852-1979	MIDDLESEX	USA	R44AI174351	Lead optimization of a novel cyclic aryl-indole efflux pump inhibitor (EPI) series in combination with levofloxacin against Pseudomonas aeruginosa	000	2	NIH	3/25/2025	$889,610
2025	2025	TAXIS PHARMACEUTICALS INC	9 DEERPARK DR STE J15	MONMOUTH JUNCTION	NJ	08852-1979	MIDDLESEX	USA	R44AI191886	Lead optimization of oral DHFR inhibitor for the treatment of multidrug-resistant N. gonorrhoeae infections.	000	1	NIH	5/16/2025	$1,000,000
															Subtotal = $1,889,610

Issue Date FY: 2024 ( Subtotal = $910,179 )
2024	2024	TAXIS PHARMACEUTICALS INC	9 DEERPARK DR STE J15	MONMOUTH JUNCTION	NJ	08852-1979	MIDDLESEX	USA	R44AI174351	Lead optimization of a novel cyclic aryl-indole efflux pump inhibitor (EPI) series in combination with levofloxacin against Pseudomonas aeruginosa	000	1	NIH	4/26/2024	$910,179
															Subtotal = $910,179

Grand Total All Awards = $3,799,789

Top